Boxer Capital, LLC Esperion Therapeutics, Inc. Transaction History

Boxer Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $5.67 Million - $10.7 Million	-500,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $11.5 Million - $17 Million	-475,000 Reduced 48.72%	500,000 $13 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $9.02 Million - $12.1 Million	-225,000 Reduced 18.75%	975,000 $39.1 Million
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $6.47 Million - $10.3 Million	-175,000 Reduced 12.73%	1,200,000 $55.2 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $17.2 Million - $36.3 Million	475,000 Added 52.78%	1,375,000 $53.9 Million
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $6.59 Million - $8.08 Million	100,000 Added 12.5%	900,000 $65.1 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $13 Million - $20.2 Million	300,000 Added 60.0%	800,000 $52.7 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $21.9 Million - $26.4 Million	500,000	500,000 $25.1 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.